Spectrum Pharmaceuticals (NASDAQ:SPPI) Stock Hits Another Low: Provides Key Financial Updates

August 17, 2021

Biopharmaceutical company focusing on acquiring, developing, and commercializing novel and targeted oncology therapies, Spectrum Pharmaceuticals (NASDAQ:SPPI), on August 12, 2021, announced financial results for the quarter ending June 30, 2021, and also gave a corporate update. The company confirmed that Momentum continues to build with poziotinib and it is targeting submission of NDA later in the year. Joe Turgeon, President, and CEO of Spectrum Pharmaceuticals said that the firm is…

Read More >>